Infection
Pipeline by Development Stage
Drug Modality Breakdown
On Market (2)
Approved therapies currently available
Competitive Landscape
26 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 41 trials with date data
Clinical Trials (41)
Total enrollment: 13,658 patients across 41 trials
Efficacy and Safety of Teicoplanin in CDAD
A De-Escalating Strategy for Antibiotic Treatment of Pneumonia in The Medical Intensive Care Unit (0787B-092)
Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients
A Comparative Phase IV Study Evaluating Efficacy & Safety Of Magnex(Cefoperazone-Sulbactam) In Intraabdominal Infections
Leukocyte Depletion of Autologous Whole Blood
Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)
A Pilot Study on Raltegravir, Tenofovir and Emtricitabine for Peri-exposure Prophylaxis for HIV Infection
Efficacy and Safety of Ertapenem Sodium (MK-0826) Following Colorectal Surgery in Chinese Adults (MK-0826-056)
Study Evaluating The Efficacy Of A Novel Ibuprofen Formulation On Fever In Patients With An Uncomplicated Acute Infection
Study to Evalutate Long-term Immunity of Hantavax in High Risk Population of HFRS
Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem
To Evaluate the Treatment Effect of an Anti-Infective Agent for Different Kinds of Infections (0826-052)
Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer Patients
Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems
Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants
A Study To Assess The Safety, Tolerability And Pharmacokinetics Of Metronidazole Injection In Healthy Japanese Subjects
Study in COPD (Chronic Obstructive Pulmonary Disease) Subjects to Investigate Safety, Tolerability, and Pharmacokinetics of Ciprofloxacin After Single Dose Inhalations of 50 mg and 75 mg Ciprofloxacin Inhalation Powder
Study Evaluating The Effect Of High-Fat Meal On Bioavailability And Pharmacokinetics Of Single Dose Of Moxidectin
Study Evaluating The Excretion Of Moxidectin Into The Breast Milk Of Lactating, Non-Breastfeeding Women
To Demonstrate the Relative Bioavailability of Azithromycin 600 mg Tablets Under Fed Conditions
Comparative Bioavailability Study of 600mg Azithromycin Monohydrate Tablets Under Fasting Conditions
Intravenous Antibiotic Treatment at Home
Real-World Observational Study Of Zavicefta to Characterize Use Patterns
Observational Study to Evaluate Peripheral IntraVenous Analysis (PIVA) in Euvolemic, Hypovolemic, and Hypervolemic Emergency Department Patients
The Use of a Novel Microbicidal Liquid Polymer for the Reduction of Pin Track Infection
Hospital-Level Care at Home for Acutely Ill Adults
Post Market Clinical Follow Up Study for Evaluation of Agluna® METS
The Incidence and Incubation Period of False Positive Cultures in Shoulder Surgery
Effect of Alcohol and Drugs of Abuse on Immune Function in Critically Ill Patients With Respiratory Failure
Influence of Bionecteurs on Catheter-associated Infection
Use of Antibiotic Carrier in Acute Periprosthetic Infections (APPI) of Total Knee Replacements
Technical Evaluation of Brahms PCT Direct
Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis
Ciprofloxacin Special Drug Use Investigation - To Investigate the Safety and Efficacy in Patients With Ciprofloxacin iv Administration Without Dilution
Epidemiologic Study Evaluating Infections in Elderly Patients
Assessment of the Safety and Efficacy of Ciproxan-I.V. in Daily Clinical Practice - Analysis Results From a Post-marketing Surveillance
A Pharmacovigilance Evaluation And Assessment Of The Prescribing Practice For Tygacil In Usual Health Care Setting
Changing Patterns of Candida Infections in Urban Medical Centers
Early Diagnosis of Candidiasis in Premature Infants
A Post-Intervention Surveillance Study Regarding the Acquisition Rate of ESBL-KP, Ecoli
Diagnosis and Management of Inflammatory and Infectious Diseases
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.